Our new promising candidate were shown to be effective against DELTA and ALPHA VARIANTS last year.
NOW Monash MIPS with the help of its partner IDT AUSTRALIA are wasting no time to redesign the new covid vaccine candidate with the new proteins carried by the new south African variant.
The biotechs from the Monash MIPS And by the victoria head of MRNA vaccine research COLIN POUTON confirm that !!!!!!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
6.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.93M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 35 | 6.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 16278 | 1 |
View Market Depth
| Last trade - 16.21pm 10/09/2025 (20 minute delay) ? |
| IDT (ASX) Chart |
Day chart unavailable